Nigel Bond joins Brother executive management team

Follows acquisition of Domino Printing Sciences by Japanese firm

Nigel Bond, CEO of Domino Printing Sciences, has become a member of the Brother executive management team.

Following Brother Industries' acquisition of the Cambridge, UK-based coding and marking and digital printing company on 11 June 2015, the appointment reflects the importance the Japanese multinational company places on Domino as a growth platform in the portfolio of its businesses.

As the first non-Japanese member to join the Executive Management Board, Bond's experience and knowledge will make an invaluable contribution to Brother's senior team in the transformation activities the company plans to undertake in the coming financial year.

'It is an honour to be invited to be a part of the Executive Management Team,' said Bond.

'Domino has a big role to play in Brother's growth projections. For this reason, in FY16/17 Brother will be investing significantly in Domino to help achieve long-term growth targets.'

Bond will continue in the role of CEO at Domino Printing Sciences.

You may also like

Packaging

New Domino Mx-Series labelling machines

Domino’s new print and apply labellers automate traceability coding for enhanced supply chain visibility
Manufacturing

Domino invests in end-to-end UV digital inkjet manufacturing

Domino Printing Sciences has revealed a strategic investment boost of £6.6m to its digital printing inks manufacturing capacity for better supply chain scalability and pharma labels
Packaging

Pharmaceuticals: Are you prepared for the 2D code sunrise?

International standards organisation GS1 is preparing to transition away from 1D barcodes to a new 2D barcode format, the GS1 Digital Link, with a push planned for 2027. Domino Printing Sciences. reveals what this new barcode standard means for manufacturers and provides advice on how to prepare for the 2027 sunrise date. Lee Metters and James Cutforth from Domino explain
Packaging

Individual dose identification: coding and marking for the new dimension in patient health and safety

On a global level, medication errors are one of the leading causes of avoidable harm in healthcare worldwide. It is estimated that the total annual cost for medication errors is $42 billion; some 5% of all patients admitted to hospital experience a medication error and an average hospital will have one medication error every 23 hours or every 20 admissions
Packaging

Serialisation beyond compliance: the gateway to competitive differentiation

Product-level serialisation has historically been associated with compliance mandates within highly regulated industries such as pharmaceuticals, medical devices and tobacco; its central premise was to prevent counterfeit goods from entering these markets
Packaging

2D codes: preparing for the new dimension

After successful implementation in sectors including tobacco and pharmaceuticals, two-dimensional barcodes or 2D codes are gaining prevalence across industries and are expected at the point of sale within the next 5 years
Packaging

Supply chain disruption: fighting counterfeit products

Counterfeit products are nothing new, but with today’s market vulnerabilities and widespread supply chain disruptions, they pose a greater threat than ever before.
Subscribe now